SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

79,383.46 2,082.06
( 2.69%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

60,935.13 -1,253.50
(-2.02%)

Nikkei 225

10,852.07 213.64
(2.01%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Torrent Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

500420

INE685A01028

479.9612701

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

TORNTPHARM

92.33

179914

EPS(TTM)

Face Value()

Div & Yield %

51.23

0.71

Back

Kalind consolidated net profit rises 175.38% in the June 2026 quarter

Jul 31,2026

Net profit of Kalind rose 175.38% to Rs 14.65 crore in the quarter ended June 2026 as against Rs 5.32 crore during the previous quarter ended June 2025. Sales rose 157.79% to Rs 35.06 crore in the quarter ended June 2026 as against Rs 13.60 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	35.06	13.60	158
OPM %	62.75	42.06	-
PBDT	22.28	6.26	256
PBT	18.61	6.26	197
NP	14.65	5.32	175

79,383.46 2,082.06 ( 2.69%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

60,935.13 -1,253.50 (-2.02%)

10,852.07 213.64 (2.01%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)